Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in Man
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 4 of the 14 sources its claims cite were checked for support.
Abstract
beta-Adrenergic receptors are increased in some tissues of experimentally thyrotoxic animals but are reported to be unchanged in mononuclear leukocytes of spontaneously thyrotoxic humans. We examined the effects of triiodothyronine (100 mug/d for 7 d) and placebo on high-affinity mononuclear leukocyte beta-adrenergic receptors in 24 normal human subjects, using a double-blind design. beta-Adrenergic receptors were assessed by specific binding of the antagonist (-)[(3)H]dihydroalprenolol. Triiodothyronine administration resulted in objective evidence of moderate thyrotoxicosis and an increase in mean (-)[(3)H]dihydroalprenolol binding from 25+/-3 to 57+/-9 fmol/mg protein (P < 0.001). The latter was attributable, by Scatchard analysis, to an increase in beta-adrenergic receptor density (967 +/- 134 to 2250 +/- 387 sites per cell, P < 0.01); apparent dissociation constants did not change. Placebo administration had no effects. Marked inter- and intraindividual variation in mononuclear leukocyte beta-adrenergic receptor density was also noted. Because this was approximately threefold greater than analytical variation, it is largely attributable to biologic variation. Thus, we conclude: (a) The finding of a triiodothyronine-induced increase in mononuclear leukocyte beta-adrenergic receptor density in human mononuclear leukocytes, coupled with similar findings in tissues of experimentally thyrotoxic animals, provides support for the use of mononuclear leukocytes to assess receptor status in man. (b) There is considerable biologic variation in beta-adrenergic receptor density in man. (c) The findings of thyroid hormone-induced increments in beta-adrenergic receptor density provide a plausible mechanism for the putative enhanced responsiveness to endogenous catecholamines of patients with thyrotoxicosis.
Overview
CoChat Summary
TL;DR
In a double-blind study of 24 normal adults, 7 days of triiodothyronine (100 μg/d) produced moderate thyrotoxicosis and increased mononuclear leukocyte β-adrenergic receptor density, while placebo had no effect. The authors conclude this provides a plausible mechanism for enhanced catecholamine responsiveness in thyrotoxicosis and supports using mononuclear leukocytes to assess receptor status in man.
Key findings
- Triiodothyronine increased specific (−)[³H]dihydroalprenolol binding from 25±3 to 57±9 fmol/mg protein (P < 0.001); placebo had no significant effect.
- Scatchard analysis attributed this to increased β-adrenergic receptor density, from 967±134 to 2,250±387 sites/cell (P < 0.01), with no change in apparent dissociation constants (1.1±0.2 to 1.1±0.3 nM).
- Triiodothyronine raised serum triiodothyronine from 145±10 to 310±20 ng/dl (P < 0.001), lowered serum thyroxine, reduced cholesterol, increased resting heart rate, and increased the heart rate–systolic blood pressure double product; plasma norepinephrine and epinephrine were not significantly altered.
- Marked inter- and intraindividual variation was noted: interindividual coefficient of variation 50%, intraindividual 58%, versus analytical variation 16%, implying biologic variation of 34–42%.
Methods
- Double-blind study of 24 normal young adults assigned alternately to triiodothyronine (25 μg four times daily for 7 days; n=12) or placebo (n=12); each subject was studied before and after treatment.
- Mononuclear leukocytes were isolated from 100 ml blood, and β-adrenergic receptors were assessed by specific binding of the antagonist (−)[³H]dihydroalprenolol, with Scatchard analysis; specific binding was defined as that displaceable by 1.0 μM (−)propranolol.
- Paired Student’s t tests compared pretreatment with post-treatment values; correlations used linear regression.
Limitations
- The paper states that experimental thyrotoxicosis from short-term exogenous thyroid hormone may be fundamentally different from long-term endogenous overproduction, and that the induced thyrotoxicosis was less severe than most spontaneous cases (1 week, no subjective manifestations, lower serum triiodothyronine).
- The paper notes that mononuclear leukocyte receptors may not reflect extravascular target tissues, and that proof of a cause–effect relationship between increased β-adrenergic receptor density and enhanced biologic responsiveness was not established.
- The paper also states that marked biologic variation may have obscured differences in prior studies comparing heterogeneous spontaneously thyrotoxic patients with controls, and that use of different (−)[³H]DHA concentrations may explain discrepant findings; evident from the text, the sample was small (12 per group) and limited to normal young adults.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 6 Not checked · 24 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Serum thyroxine concentrations declined appropriately.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was considerable inter- and intraindividual variation in mononuclear leukocyte β-adrenergic receptor density (calculated by Scatchard analysis) in the subjects studied.”
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The intraindividual coefficient of variation, calculated from the determinations performed before and after placebo administration (see below), was similar, 58%.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the placebo had no significant effect on specific (-)[³H]DHA binding to mononuclear leukocyte preparations (Fig. 1).”
plainn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant correlations were detected between mononuclear leukocyte (-)[³H]DNA binding and basal plasma norepinephrine (r = -0.096) or epinephrine (r = 0.164) concentrations nor between binding and serum triiodothyronine (r = -0.070) or thyroxine (r = -0.207) levels in the pretreatment samples from the entire group of 24 subjects.”
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 32 claims and to verify the 2 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid hormone increases sensitivity to catecholamines and sensitizes beta-2 adrenergic receptors. This results in the stimulation of Na+/K+ ATPase channels in the liver and skeletal muscle allowing for potassium to move into cells [9].”
From Thyrotoxic Periodic Paralysis With Hypokalemia: A Case Study (2023) · cites this paper as [9]
Citations
Cites
Thyroid hormone regulation of beta-adrenergic receptor number.
Williams, L. T., Lefkowitz, R. J., Watanabe, A. M., Hathaway, D. R., & Besch, H. R. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40528-x · Cited by 453
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
Williams, L. T., Snyderman, R., & Lefkowitz, R. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108254 · Cited by 322
Fat cell adenylate cyclase and beta-adrenergic receptors in altered thyroid states.
Malbon, C. C., Moreno, F. J., Cabelli, R. J., & Fain, J. N. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38155-3 · Cited by 217
Plasma Noradrenaline and Adrenaline in Patients with Thyrotoxicosis and Myxoedema
Christensen, N. J. (1973) · Clinical Science · doi:10.1042/cs0450163 · Cited by 210
DAVIES, A. O., & LEFKOWITZ, R. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-599 · Cited by 198
COULOMBE, P., DUSSAULT, J. H., & WALKER, P. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1185 · Cited by 170
Plasma catecholamines in diabetes
Cryer, P. E., Silverberg, A. B., Santiago, J. V., & Shah, S. D. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90220-6 · Cited by 169
Self-citationCRYER, P. E., SANTIAGO, J. V., & SHAH, S. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-6-1025 · Cited by 155
Self-citationThyroxine and propylthiouracil effects in vivo on alpha and beta adrenergic receptors in rat heart
Ciaraldi, T., & Marinetti, G. V. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91615-1 · Cited by 151
Beta adrenergic receptors in lymphocyte subpopulations
Bishopric, N. H., Cohen, H. J., & Lefkowitz, R. J. (1980) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(80)90173-6 · Cited by 148
Cited by
Adrenergic Receptors in Man: Direct Identification, Physiologic Regulation, and Clinical Alterations
Motulsky, H. J., & Insel, P. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207013070104 · Cited by 401
Lin, S.-H. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.1.99 · Cited by 254
Thyroid–Adrenergic Interactions: Physiological and Clinical Implications
Silva, J. E., & Bianco, S. D. C. (2008) · Thyroid · doi:10.1089/thy.2007.0252 · Cited by 252
Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism
Levey, G. S., & Klein, I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90533-j · Cited by 213
β-Adrenergic blockade for the treatment of hyperthyroidism
Geffner, D. L., & Hershman, J. M. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90681-z · Cited by 168
Metadata
- Authors
- Ginsberg, A. M., Clutter, W. E., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Ginsberg, Ann M.
- Venue
- Journal of Clinical Investigation
- Published
- 1981-06-01
- Volume
- 67
- Issue
- 6
- Pages
- 1785-1791
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370757
- OpenAlex
- W2145338884
- Cited by
- 99
- References
- 38
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2021: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- thyrotoxicosis, triiodothyronine, beta-adrenergic receptors, mononuclear leukocytes, receptor density, dihydroalprenolol binding, thyroid hormones, catecholamine responsiveness, interindividual variability
- MeSH terms
- Adult, Binding Sites, Blood Cell Count, Blood Pressure, Catecholamines, Double-Blind Method, Female, Heart Rate, Humans, Hyperthyroidism, Male, Monocytes, Receptors, Adrenergic, Receptors, Adrenergic, beta, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in Man. https://app.cochat.ai/papers/10.1172/jci110218
- The paper
- Ginsberg, A. M., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1981). Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in Man. Journal of Clinical Investigation. https://doi.org/10.1172/jci110218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.